Clinical Trial Confirms Pfizer Covid Vaccine Safe For Kids Aged 5-11 Years; Firm To Seek Authorisation For Use Soon

<p><strong>New Delhi:</strong> Pfizer and BioNTech on Monday said that the data from the clinical trials confirms their coronavirus vaccine was safe and produced a robust immune response in children aged 5 to 11.&nbsp;</p> <p>In a joint statement issued today, the US giant Pfizer and its German partner said that their vaccine was safe, well tolerated and showed robust neutralising antibody responses in participants five to 11 years of age. They said that the vaccine would be administered at a lower dosage than for people over 12.&nbsp;</p> <p>According to media reports, Pfizer plan to seek regulatory approval soon. They will submit their data to regulatory bodies in the European Union, the United States and around the world as soon as possible to ask for authorisation to use the vaccine in children in that age range.&nbsp;&nbsp;</p> <p><em><strong>(This is a developing story. More details awaited.)&nbsp;</strong></em></p>

from covid-19 https://ift.tt/2XvimR4